Wound care market sees slow growth, NPWT and biologics are strong areas

A new study by market analysis company Espicom, headquartered in Chichester, UK, suggests advanced wound care products are not reaching their potential value or audience and that their use is constrained by tightened healthcare spending and slow clinical adoption, particularly in Asia. The report, “The Global Advanced Wound Care Market to 2017,” noted that while the international market saw double-digit growth before 2008, the market has slowed more recently, with growth affected by intense competition.

A new study by market analysis company Espicom, headquartered in Chichester, UK, suggests advanced wound care products are not reaching their potential value or audience and that their use is constrained by tightened healthcare spending and slow clinical adoption, particularly in Asia. The report, “The Global Advanced Wound Care Market to 2017,” noted that while the international market saw double-digit growth before 2008, the market has slowed more recently, with growth affected by intense competition.

Read the original post:
Wound care market sees slow growth, NPWT and biologics are strong areas